Finwire Media publishes presentation of NanoEcho ahead of IPO

Ahead of the upcoming stock exchange listing, Finwire Media has published a presentation where our CEO, Linda Persson, discusses NanoEcho’s technology with the aim of improving the diagnosis of rectal cancer and creating significant health-economic benefits for society. Linda also shares her insights on the company’s strategy to get the system approved and implemented as a standard in healthcare.

Watch the full presentation here: https://lnkd.in/gCGFufBY

More information about the ongoing share issue and how you can participate is available on our website: https://lnkd.in/dH_uUs5h

NanoEcho’s innovative method, with its high precision, aims to facilitate the differentiation between diseased and healthy tissue and at the same time determine a more precise localization of cancerous tissue. The goal is to provide a more reliable diagnosis of, for example cancer diseases, that has the potential to contribute to cost-effectiveness in the health care.

NanoEcho AB
Scheelevägen 19,
223 63 Lund
info@nanoecho.se

Facebook Linkedin Youtube Envelope
Copyright 2024 NanoEcho © All Rights Reserved.
Privacy policy

We use cookies to enhance your experience on our website and analyze our traffic. By clicking ‘Accept,’ you consent to our use of cookies. You can learn more about the types of cookies we use and how to manage them in our privacy policy.

Accept